Biosimilars in Canada: Navigating the Regulatory and IP Maze

Tuesday, September 22, 2026, 1 pm - 2 pm ET
Held on Tuesday, September 22, 2026, 1 pm - 2 pm ET

Biosimilars are reshaping the Canadian pharmaceutical landscape, raising important regulatory, patent and trademark considerations for both biologics and biosimilar industries. This webinar will provide a practical overview of the Canadian framework governing biosimilar products including:

  • Health Canada’s approval pathway
  • Provincial and territorial substitution policies
  • Role of the Patented Medicine Prices Review Board (PMPRB)
  • Key trademark and branding considerations
  • Availability, if any, of patent listing and Certificates of Supplementary Protection

Continuing Professional Development

This program contains up to 1 hour Substantive where applicable.

  Hours
Law Society of Ontario1
Barreau du Québec1
Law Society of British Columbia1
Law Society of Saskatchewan1
Law Society of Manitoba1
Law Society of Alberta1
New York State CLE Board1

** An application for accreditation of the session will be submitted upon request by a participant

Register

Purchase

Member Price

Register

Individual $90.00 + tax Sign In
Group: 4 to 5 people $355.00 + tax Sign In
Group: 6 to 10 people $599.00 + tax Sign In
Group: 11 to 15 people $899.00 + tax Sign In
Group: 16 or more people $1,399.00 + tax Sign In
Proceed to Checkout

Non-Member Price

Register

Individual $160.00 + tax
Group: 4 to 5 people $499.00 + tax
Group: 6 to 10 people $799.00 + tax
Group: 11 to 15 people $1,199.00 + tax
Group: 16 or more people $1,799.00 + tax
Proceed to Checkout

****Financial aid may be available to participate in this webinar. Applicants will be considered on the basis of their annual income. Inquiries: education@ipic.ca

Logistics

Participants will view the webinar presentation online using Zoom. A web link and audio coordinates will be provided to the registrant the day before the webinar.  

Inquiries

education@ipic.ca
613-234-0516

Program subject to change.